Bespoke Extracts, INC

Bespoke Extracts, Inc. has amended its senior secured promissory notes, extending the maturity date to August 14, 2026, increasing the interest rate, and issuing shares as an extension fee.

Bespoke Extracts, operating as The Joint Company, reported record Q3 2025 revenue and improved net loss, driven by increased pre-roll production and margin expansion in Colorado.

Bespoke Extracts, Inc. has extended the maturity date of its $849,500 Senior Note with Infinity Management, LLC from June 30, 2026, to June 30, 2027.

Bespoke Extracts, Inc. (OTCQB: BSPK) announced its first-quarter 2025 financial results, showcasing revenue growth and reduced net loss driven by strategic rebranding to The Joint Company and new product launches, despite an overall market contraction in Colorado.

Bespoke Extracts, Inc. announces the resignation of Assurance Dimensions as its independent auditor and the engagement of Stephano Slack LLC as the new auditor, effective May 8, 2025.

Bespoke Extracts Colorado, LLC, a subsidiary of Bespoke Extracts, Inc., has entered into an agreement with WL Holdings, Ltd to convert unpaid rent into a promissory note and amend their lease agreement.

Bespoke Extracts, Inc. announced a significant increase in sales and gross profit for the nine months ended September 30, 2025, alongside a reduced net loss, but continues to face substantial doubt regarding its ability to continue as a going concern.

Bespoke Extracts, Inc. reported increased sales and a narrower net loss for the quarter and six months ended June 30, 2025, but faces significant liquidity challenges and a going concern warning.

Bespoke Extracts, Inc. reported a reduced net loss of $260,521 for the first quarter of 2025, driven by increased sales and production efficiencies, but continues to face substantial doubt about its ability to continue as a going concern due to a significant working capital deficit and reliance on external financing.

Bespoke Extracts, Inc. saw a rise in sales during the third quarter of 2024, but the company still experienced a net loss and faces ongoing concerns about its ability to continue as a going concern.

Bespoke Extracts, Inc. saw a significant increase in sales during the second quarter of 2024, but continues to operate with a working capital deficit and negative cash flows, raising concerns about its ability to continue as a going concern.

Bespoke Extracts, Inc. saw a significant increase in sales during the first quarter of 2024, but continues to operate with a working capital deficit and negative cash flows, raising concerns about its ability to continue as a going concern.

Bespoke Extracts, Inc. reports increased sales for the year ended December 31, 2024, but continues to face significant financial challenges, including operating losses and a working capital deficit.

Bespoke Extracts, Inc. reports its annual results for 2023, highlighting a shift towards the regulated cannabis market and away from CBD, with a focus on branded pre-rolled marijuana products.

Bespoke Extracts, Inc. President and Director Garth Tyler Hunter was granted 200,000 restricted common shares, vesting in one year.

Bespoke Extracts CEO Michael Feinsod increased his beneficial ownership by purchasing 3,500 shares of common stock in two separate transactions.

Bespoke Extracts, Inc. CEO Michael Feinsod purchased 2,500 shares of common stock at $0.19 per share, increasing his beneficial ownership to over 2.5 million shares.

Bespoke Extracts' CEO and 10% owner, Michael Feinsod, purchased 2,500 shares of common stock at $0.20 per share, signaling confidence.

Bespoke Extracts, Inc. CEO and Director Michael Feinsod has acquired 8,000 shares of common stock, increasing his beneficial ownership to over 2.5 million shares.

CEO Michael Feinsod reports purchasing additional shares of Bespoke Extracts, Inc. on May 9th and May 12th, 2025.